Future prospects in antiviral therapy
- 24 Downloads
Two important stumbling blocks to the development of effective and nontoxic antiviral drugs are the intracellular localization of the virus and the fact that a virus uses host cell functions to multiply. Therefore, new antiviral drugs must act on a virus-specific function. Most currently available useful antiviral drugs are the result of compound screening of large numbers of possible agents. Advances in our understanding of the molecular biology and biochemistry of the viral multiplication cycle and new laboratory techniques for determining the molecular sites of action have now made it possible to develop and screen new antiviral drugs in a more purposeful manner. Another possible option in antiviral therapy is combination therapy using drugs that enhance the therapeutic effect or diminish side-effects. The most promising new antiviral drugs are discussed according to the different steps they affect in the viral multiplication process. Combination therapy is also reviewed.
KeywordsAntiviral drugs Future prospects
Unable to display preview. Download preview PDF.
- 1.Wiltink EHH, Janknegt R. Antiviral drugs. Pharm Weekbl [Sci] 1991;13:58–69.Google Scholar
- 2.Sim IS. Virus replication: target functions and events for virus-specific inhibiters. In: Galasso GJ, Whitley RJ, Merigan TC, eds. Antiviral agents and viral diseases of man. 3rd ed. New York: Raven Press, 1990:1–47.Google Scholar
- 6.Moore JP, Weiss RA, Passive primate protection. Nature 1991;352:371–7.Google Scholar
- 27.Hardy WD, Spector S, Polsky B, Crumpacker C, Holland G, Freeman W, et al. Combined ganciclovir (GCV) and recombinant humangranulocyte-macro-phage-stimulating factor (GM-CSF) vs ganciclovir alone for cytomegalovirus (CMV) retinitis in AIDS, [Abstract]. Thirtieth Interscience Conference on Antimicrobial Agents and Chemotherapy, 1990; New Orleans, abstract 9.Google Scholar